IGC Pharma, Inc. is a clinical-stage pharmaceutical company that is focused on Alzheimer's disease, developing innovative solutions to address this devastating illness. It has two investigational ...

IGC Pharma Revenue Declines 51% YoY Due To Completion Of Its Legacy Project In India, Highlights Important Milestones In Alzheimer's Research Nina Zdinjak Hedge Fund Settles At $2.25M With SEC For ...

Shares of IGC Pharma, Inc. (NYSEMKT:IGC – Get Free Report) were down 7.4% on Thursday .The stock traded as low as $0.32 and last traded at $0.30. Approximately 214,616 shares changed hands ...

IGC Industries, operating in the Textiles - General sector and classified as a Smallcap on the BSE, currently has its share price at ₹6.15. The stock has experienced fluctuations today, with a ...

POTOMAC, MD / ACCESS Newswire / March 26, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC Pharma" or the "Company") today announced additional positive interim results from its ongoing Phase 2 ...

IGC Pharma (IGC) announced the expansion of its ongoing Phase 2 CALMA clinical trial with the addition of Butler Hospital’s Memory and Aging Program, a research center affiliated with the Warren ...

IGC Pharma (IGC) announced the expansion of its ongoing Phase 2 CALMA clinical trial with the addition of Butler Hospital’s Memory and Aging Program, a research center affiliated with the Warren ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...